Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Banyu Committed to Simultaneous Global Development
May 14, 2007
- Nihon Medi-Physics Completes Nationwide Distribution System for FDG
May 14, 2007
- JPMA Seminar on Innovation
April 30, 2007
- JPMA to Propose New Drug Pricing System in May
April 30, 2007
- Joint Consultation Services by PMDA, FDA, EMEA Suggested by Mr Nakagaki of Korosho
April 30, 2007
- REGULATORY NEWS IN BRIEF
April 30, 2007
- Korosho Group Discusses Direct Contracts between Sponsors and Investigators
April 30, 2007
- Symposium
April 30, 2007
- R&D NEWS IN BRIEF
April 30, 2007
- India Featured at CPhi 2007
April 30, 2007
- Roche to Acquire BioVeris
April 30, 2007
- SymBio to Develop Bendamustine in Asia-Pacific Rim Countries
April 30, 2007
- MEDICAL DEVICE NEWS IN BRIEF
April 30, 2007
- BUSINESS NEWS IN BRIEF
April 30, 2007
- OINION：Times Are a Changin'
April 30, 2007
- NEW PRODUCTS
April 30, 2007
- Diabetes Care Should Be Standardized: Critical Path Seminar
April 30, 2007
- Zydus Acquires Nippon Universal
April 30, 2007
- Cancer Deaths Should Decrease by Half in Next 10 Years: Dr Kakizoe
April 30, 2007
- Generics to Be NHI Price-Listed Twice a Year from FY2007
April 30, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…